example@example.com 000-111-222
  • About Us
  • News Room
  • Resources
  • Why Sri Lanka
  • Contact Us
  • Login
Remediumone
  • Home
  • Our Services
  • Our Expertise
  • Our Collaborators
  • South Asia Forum
  • Clinical Trials Unit
Remediumone
  • Home
  • Our Services
  • Our Expertise
  • Our Collaborators
  • South Asia Forum
  • Clinical Trials Unit

Case Studies

  • Oncology
  • Endocrinology
  • Immunology
  • Neurology
  • Gastroenterology
  • Cardiology
  • Ophthalmology
  • Toxicology
  • Infectious Diseases
  • Rare Diseases
December 18, 2021

By: admin

Immunoglobulin A Nephropathy Clinical Trial Initiation

Immunoglobulin A Nephropathy is also known as Berger’s disease, is a kidney disease that is caused by deposition of IgA. This causes inflammation and damage the Kidneys. Scientists believe this to be a autoimmune Kidney disease.

RemediumOne will soon be recruiting patients for a clinical trial involving patients with  Immunoglobulin A Nephropathy. This is a treatment trial which aims at reducing or halting the progression of Immunoglobulin A Nephropathy.

RemediumOne (Pvt) Ltd.

No 41/10, Guildford Crescent,
Colombo 07, Sri Lanka

+94112665266

+94112665300

inquiries@remediumone.com

Quick Links

  • Home
  • About Us
  • Our Services
  • Our Expertise
  • Contact Us

Follow Us

Remediumone © 2023 All Rights Reserved.

Developed by Lankacom

Search